(Adnkronos) - “Non chiediamo risorse economiche alle istituzioni, ma legislazioni che diano conto dell'impegno degli investimenti che vengono fatti in ricerca, innovazione e produzione in Italia, che premino l'export, la fiscalità nel nostro Paese e l'investimento in ricerca”. Lo ha dettoSergio Dompé, presidente Gruppo biofarmaceutico Dompé, all’evento per la pubblicazione del Rapporto Fondazione Edison sulle Fab13, che fotografa l'industria farmaceutica italiana.
Category
🗞
NewsTranscript
00:00Today we have a theme of sustainability, of innovation, of the world that connects health
00:15to what is the development of the industry.
00:19It is very important because it is not only about health, which is the fundamental point
00:27of our existence, but it is also about industrial strength, it is about guarantees for our
00:35citizens to be able to have internally in our country the productions that in times
00:41of crisis, as we have seen in Covid, become strategic.
00:45So it is very important that there is an awareness of how important it is to be able to maintain
00:53and develop an industry that today has more than 75% average export and that is already
01:00one of the engines of our economy, and in particular that of knowledge.
01:07We do not ask for economic resources, we ask for laws that take into account the commitment
01:16and investments that are made in research on innovation and production in Italy,
01:21that reward export, that reward taxation in our country and investment in research.
01:28A theme for everyone, that of access to the data of our national health service, which
01:33can be one of the elements of competitiveness of our system.
01:38We must not forget that with the same effort with which we have created this situation
01:45of competitiveness, we must face the future because a delay of a month causes a year
01:52of loss of competitiveness.